
Biden’s IRA Is Harming Cancer Patients
Democrats’ 2022 Inflation Reduction Act wasn’t designed to kill cancer innovation, but new evidence reveals that’s what it’s doing. The law strongly discourages drug companies from performing the “follow-on” research after initial discoveries that accounts for a disproportionate share of progress in the fight against cancer. The crux of the problem is that the IRA imposes price caps that shorten the effective life of a patent and applies those price controls even to later-approved uses.…
Learn More






